Last Posted: May 05, 2021
- First genetically modified mosquitoes released in the United States
E Watz, Nature News, May 4, 2021
- Health impact of routine immunisation service disruptions and mass vaccination campaign suspensions caused by the COVID-19 pandemic: Multimodel comparative analysis of disruption scenarios for measles, meningococcal A, and yellow fever vaccination in 10 low- and lower middle-income countries
K Gaythorpe et al, MEDRXIV, January 26, 2021
- Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria
Scientific Reports, February 2020
- 'Six million lives could be saved by 2030' through data science,
by Gilbert Nakweya, Sci Dev Net, October 10, 2019
- Health: Ending millions of preventable deaths through equitable, data-driven health systems in communities around the world
Rockefeller Foundation, 2019
- Transgenic Aedes aegypti Mosquitoes Transfer Genes into a Natural Population.
Evans Benjamin R et al. Scientific reports 2019 Sep (1) 13047
- T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus.
Bovay Amandine, et al. European journal of immunology 2018 0 (2) 258-272
- A Multipurpose, High-Throughput Single-Nucleotide Polymorphism Chip for the Dengue and Yellow Fever Mosquito, Aedes aegypti.
Evans Benjamin R et al. G3 (Bethesda) 2015 (5) 711-8
- Zika Virus
- Yellow fever
From NCATS Genetic and Rare Diseases Information Center
- Interindividual variation in the response by fibrinogen, C-reactive protein and interleukin-6 to yellow fever vaccination.
Verschuur Maartje, et al. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004 7 (5) 399-404
- Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination.
Hacker U T, et al. Clinical and experimental immunology 2001 9 (3) 465-9
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.